Literature DB >> 29150001

CRISPR History: Discovery, Characterization, and Prosperity.

Wenyuan Han1, Qunxin She2.   

Abstract

CRISPR research is a very young research field since it was only 10years ago when the system was found to confer antiviral defense. Nevertheless, there has been an explosion of publications in CRISPR research in the past 5years. The research was started with the comparative genomics of microbial genomes early this century, which revealed the prevalence of clustered regularly interspaced short palindromic repeats (CRISPR) and CRISPR-associated (Cas) in bacteria and archaea. Series of hypotheses were made based on bioinformatics analyses and tested experimentally within a few years after the CRISPR acronym was coined. These findings have not only led to the discovery of the unique antiviral system and the involved molecular mechanisms, but also to the development of CRISPR technology with various well-developed applications, such as genome editing in all three domains of life. Currently, widespread research efforts in multiple research disciplines have constantly yielded new insights into molecular mechanisms of CRISPR antiviral immunity, and new applications in scientific research and biomedical applications. Retrospectively, it is worth pointing out that close interdisciplinary interactions have fostered series of discoveries in the CRISPR research and worked as the driving force in the fast developing research field.
Copyright © 2017. Published by Elsevier Inc.

Keywords:  CRISPR loci; CRISPR technology; Cascade; DNA interference; RNP; anti-CRISPR systems; cas gene cassettes; crRNA biogenesis; gRNA-Cas9; spacer adaptation

Mesh:

Year:  2017        PMID: 29150001     DOI: 10.1016/bs.pmbts.2017.10.001

Source DB:  PubMed          Journal:  Prog Mol Biol Transl Sci        ISSN: 1877-1173            Impact factor:   3.622


  10 in total

1.  Tolerance of Sulfolobus SMV1 virus to the immunity of I-A and III-B CRISPR-Cas systems in Sulfolobus islandicus.

Authors:  Tong Guo; Wenyuan Han; Qunxin She
Journal:  RNA Biol       Date:  2018-07-09       Impact factor: 4.652

2.  Characterization of a novel type III CRISPR-Cas effector provides new insights into the allosteric activation and suppression of the Cas10 DNase.

Authors:  Jinzhong Lin; Mingxia Feng; Heping Zhang; Qunxin She
Journal:  Cell Discov       Date:  2020-05-12       Impact factor: 10.849

3.  A Type III-B Cmr effector complex catalyzes the synthesis of cyclic oligoadenylate second messengers by cooperative substrate binding.

Authors:  Wenyuan Han; Stefano Stella; Yan Zhang; Tong Guo; Karolina Sulek; Li Peng-Lundgren; Guillermo Montoya; Qunxin She
Journal:  Nucleic Acids Res       Date:  2018-11-02       Impact factor: 16.971

Review 4.  History of CRISPR-Cas from Encounter with a Mysterious Repeated Sequence to Genome Editing Technology.

Authors:  Yoshizumi Ishino; Mart Krupovic; Patrick Forterre
Journal:  J Bacteriol       Date:  2018-03-12       Impact factor: 3.490

Review 5.  Cas13d: A New Molecular Scissor for Transcriptome Engineering.

Authors:  Rahul Gupta; Arijit Ghosh; Rudra Chakravarti; Rajveer Singh; Velayutham Ravichandiran; Snehasikta Swarnakar; Dipanjan Ghosh
Journal:  Front Cell Dev Biol       Date:  2022-03-31

Review 6.  Rational development of mycobacteria cell factory for advancing the steroid biomanufacturing.

Authors:  Xin-Xin Wang; Xia Ke; Zhi-Qiang Liu; Yu-Guo Zheng
Journal:  World J Microbiol Biotechnol       Date:  2022-08-17       Impact factor: 4.253

7.  Inactivation of Target RNA Cleavage of a III-B CRISPR-Cas System Induces Robust Autoimmunity in Saccharolobus islandicus.

Authors:  Yan Zhang; Jinzhong Lin; Xuhui Tian; Yuan Wang; Ruiliang Zhao; Chenwei Wu; Xiaoning Wang; Pengpeng Zhao; Xiaonan Bi; Zhenxiao Yu; Wenyuan Han; Nan Peng; Yun Xiang Liang; Qunxin She
Journal:  Int J Mol Sci       Date:  2022-07-31       Impact factor: 6.208

Review 8.  Strategies to improve homology-based repair outcomes following CRISPR-based gene editing in mosquitoes: lessons in how to keep any repair disruptions local.

Authors:  Micaela Finney; Joseph Romanowski; Zach N Adelman
Journal:  Virol J       Date:  2022-07-30       Impact factor: 5.913

9.  Characterization of a novel type III CRISPR-Cas effector provides new insights into the allosteric activation and suppression of the Cas10 DNase.

Authors:  Jinzhong Lin; Mingxia Feng; Heping Zhang; Qunxin She
Journal:  Cell Discov       Date:  2020-05-12       Impact factor: 10.849

Review 10.  Large Animal Models of Huntington's Disease: What We Have Learned and Where We Need to Go Next.

Authors:  David Howland; Zdenka Ellederova; Neil Aronin; Deborah Fernau; Jill Gallagher; Amanda Taylor; Jon Hennebold; Alison R Weiss; Heather Gray-Edwards; Jodi McBride
Journal:  J Huntingtons Dis       Date:  2020
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.